Adacel-Polio 29 Unit (Poliovirus Type 1 Mahoney (Inactivated) SUSPENSION) 29 UNIT

ADACEL-POLIO 29 Unit is a vaccine designed to protect against polio. This suspension is administered intramuscularly and is manufactured by Sanofi Pasteur Limited in Canada. It is commonly used for immunization against polio virus type 1 Mahoney.

Strength

29 UNIT

Pack Size

0.5ML

Manufacturer / TM Owner

SANOFI PASTEUR LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ADACEL-POLIO 29 Unit is primarily used for the prevention of polio, a viral infection that can cause paralysis and other serious health complications. This vaccine is part of a broader immunization strategy to eradicate polio. It is often administered to individuals who have not previously received the polio vaccine or who require a booster dose.

Side Effects

Common effects of the ADACEL-POLIO vaccine may include mild soreness, redness, or swelling at the injection site. Some individuals may experience mild fever, fatigue, or headache. These effects are typically temporary and resolve within a few days.

Precautions & Warnings

ADACEL-POLIO should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to previous polio vaccines or any component of this vaccine should consult their healthcare provider before receiving it. It is important to inform the healthcare provider about any current illnesses or medications.

Avoid Interactions

There are no specific known interactions with other medications, but it is always advisable to inform your healthcare provider about all medications and supplements you are taking. Alcohol and other substances generally do not interact with vaccines, but it is best to follow the advice of your healthcare provider.

Frequently Asked Questions

ADACEL-POLIO 29 Unit is used for the prevention of polio, a viral infection that can cause paralysis and other serious health complications.

ADACEL-POLIO 29 Unit is administered intramuscularly, typically in the upper arm or thigh.

Common side effects may include mild soreness, redness, or swelling at the injection site, as well as mild fever, fatigue, or headache.

Individuals with a history of severe allergic reactions to previous polio vaccines or any component of this vaccine should consult their healthcare provider before receiving it.

There are no specific known interactions with other medications, but it is always advisable to inform your healthcare provider about all medications and supplements you are taking.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.